✦ LIBER ✦

Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice

✍ Scribed by Fehmida Visnegarwala; Mario Maldonado; Prasuna Sajja; Jennifer L. Minihan; Maria C. Rodriguez-Barradas; Oliver Ong; Christopher J. Lahart; Mirza Qasim Hasan; Ashok Balasubramanyam; A.Clinton White Jr

Book ID: 108174229
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 128 KB
Volume: 49
Category: Article
ISSN: 0163-4453
DOI: 10.1016/j.jinf.2003.09.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lipid Lowering Therapy with Fluvastatin

Lipid Lowering Therapy with Fluvastatin and Pravastatin in Patients with HIV Infection and Antiretroviral Therapy: Comparison of Efficacy and Interaction with Indinavir

✍ A. Benesic; M. Zilly; F. Kluge; B. Weißbrich; R. Winzer; H. Klinker; P. Langmann 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 284 KB

No pol mutation is associated independen

No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy

✍ Nicola Gianotti; Laura Galli; Maurizio Zazzi; Valeria Ghisetti; Stefano Bonora; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 2 views

## Abstract An investigation was undertaken to determine whether specific __pol__ mutations hinder long‐term immune recovery regardless of virological response. In total, 826 patients with >50 HIV RNA copies/ml, who underwent genotypic resistance testing between 1 January 2000 and 31 December 2003

The Association of Stigma with Self-Repo

The Association of Stigma with Self-Reported Access to Medical Care and Antiretroviral Therapy Adherence in Persons Living with HIV/AIDS

✍ Jennifer N. Sayles; Mitchell D. Wong; Janni J. Kinsler; David Martins; William E 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

CD4 T cell measurements in the managemen

CD4 T cell measurements in the management of antiretroviral therapy—A review with an emphasis on pediatric HIV-infected patients

✍ Maurice R.G. O'Gorman; Lynn S. Zijenah 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

Effects of potent antiretroviral therapy

Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV-1 subtypes A–D

✍ Ann Atlas; Tran Thi Thanh Ha; Anna Lindström; Anna Nilsson; Annette Alaeus; Fran 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract HIV‐1 genetic subtypes might have a different impact on disease progression and response to antiretroviral therapy (ART). Few data are available on the immune activation profile in patients with different HIV‐1 subtypes. We have tested by ELISA the plasma levels of an immune activation

Drug resistance mutations and newly reco

Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients

✍ Carlo Torti; Eugenia Quiros-Roldan; Laura Monno; Andrea Patroni; Annalisa Saraci 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract This study aimed at identifying HIV‐1 protease amino acid changes associated with protease inhibitor (PI) exposure and susceptibility. New amino acid substitutions were correlated with the number of experienced PIs, reaching statistical significance only for those at positions 3, 44, an